Literature DB >> 570136

Plasma prolactin in juvenile diabetics. 24-h studies with somatostatin.

K F Hanssen, S E Christensen, A P Hansen, K Lundbaek, P A Torjesen, J Weeke.   

Abstract

In normal subjects during 24-hours saline infusion, plasma prolactin showed a number of small rises during day and night. The mean night-time level was significantly higher than the day-time level (8.2 +/- 0.6 ng/ml as against 4.7 +/- 0.5 ng/ml). In 12 insulin-dependent diabetics the 24 h plasma prolactin pattern was identical to that found in normals. Somatostatin infusion (4 mg/24 h in normals; 2--6 mg/24 h in diabetics) had no effect on the 24 h plasma prolactin pattern in either normals or in diabetics.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 570136     DOI: 10.1007/bf01219645

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  16 in total

1.  Specific inhibition by somatostatin of growth hormone release after hypoglycaemia in normal man.

Authors:  G Copinschi; E Virasoro; L Vanhaelst; R Leclercq; J Golstein; M L'Hermite
Journal:  Clin Endocrinol (Oxf)       Date:  1974-10       Impact factor: 3.478

2.  Action of growth hormone release inhibitory hormone on prolactin release in rat pituitary cell cultures.

Authors:  N H Grant; D Sarantakis; J P Yardley
Journal:  J Endocrinol       Date:  1974-04       Impact factor: 4.286

3.  Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly.

Authors:  R Hall; G M Besser; A V Schally; D H Coy; D Evered; D J Goldie; A J Kastin; A S McNeilly; C H Mortimer; C Phenekos; W M Tunbridge; D Weightman
Journal:  Lancet       Date:  1973-09-15       Impact factor: 79.321

4.  Sleep-related, nychthermeral and briefly episodic variation in human plasma prolactin concentrations.

Authors:  D C Parker; L G Rossman; E F Vander Laan
Journal:  J Clin Endocrinol Metab       Date:  1973-06       Impact factor: 5.958

5.  Serum growth hormone patterns in juvenile diabetes.

Authors:  A P Hansen
Journal:  Dan Med Bull       Date:  1972-04

6.  Effect of ovine prolactin administration on glucose metabolism and plasma insulin levels in the dog.

Authors:  I Rathgeb; B Winkler; R Steele; N Altszuler
Journal:  Endocrinology       Date:  1971-03       Impact factor: 4.736

7.  Diabetic retinopathy and prolactin.

Authors:  A Froland; C Hagen; E Lauritzen
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321

8.  24-hour studies of the effects of somatostatin on the levels of plasma growth hormone, glucagon, and glucose in normal subjects and juvenile diabetics.

Authors:  S E Christensen; A P Hansen; J Weeke; K Lundbaek
Journal:  Diabetes       Date:  1978-03       Impact factor: 9.461

9.  Increased serum prolactin in diabetic ketoacidosis; correlation between serum sodium and serum prolacting concentration.

Authors:  K F Hanssen; P A Torjesen
Journal:  Acta Endocrinol (Copenh)       Date:  1977-06

10.  Prolactin: a diabetogenic hormone.

Authors:  R Landgraf; M M Landraf-Leurs; A Weissmann; R Hörl; K von Werder; P C Scriba
Journal:  Diabetologia       Date:  1977-04       Impact factor: 10.122

View more
  3 in total

1.  Effect of 4 weeks of octreotide treatment on prolactin, thyroid stimulating hormone and thyroid hormones in acromegalic patients. A double blind placebo-controlled cross-over study.

Authors:  M Andersen; T B Hansen; J Bollerslev; P Bjerre; H D Schrøder; C Hagen
Journal:  J Endocrinol Invest       Date:  1995-12       Impact factor: 4.256

Review 2.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

3.  Study of pituitary secretion in relation to retinopathy in patients with juvenile diabetes mellitus.

Authors:  G A Cerasola; M Donatelli; D Sinagra; V Russo; L M Amico; G Lodato
Journal:  Acta Diabetol Lat       Date:  1981 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.